IAM
NEO icon

Integre Asset Management’s NeoGenomics NEO Stock Holding History

Integre Asset Management’s Portfolio NEO Stock Details NEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-19,177
Closed -$170K – 139
2017
Q4 		$170K Buy
+19,177
New +$177K 0.1% 110

Other funds holding NEO

GE
General Electric Evendale, Ohio $369M AUM 19.65% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
GIP
Granite Investment Partners El Segundo, California $1.95B AUM 49.89% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
FPC
Falcon Point Capital San Francisco, California $11.9M AUM 55.76% 1-Year Est. Return

Integre Asset Management's NEO Position: Q1 2018 in Review

Integre Asset Management sold out of NeoGenomics (NEO) in Q1 2018, closing a stake of 19,177 shares — an estimated $170K sold.

Integre Asset Management first reported a position in NEO in Q4 2017 and held it in 1 quarter. The position peaked at $170K in Q4 2017. 137 funds tracked by Wall St. Rank hold NEO as of Q1 2018.

  • Integre Asset Management reported no remaining NeoGenomics position as of Q1 2018 after selling out during the quarter.
  • Integre Asset Management sold 19,177 NeoGenomics shares in Q1 2018, an estimated $170K.
  • Integre Asset Management first reported a position in NeoGenomics in Q4 2017 and held it in 1 quarter.
  • Integre Asset Management's NeoGenomics position peaked at $170K in Q4 2017.
  • 137 funds tracked by Wall St. Rank held NeoGenomics as of Q1 2018.

Based on Integre Asset Management's 13F filing for Q1 2018, filed 16 May 2018.